Bioshield legislation
This article was originally published in The Gray Sheet
Executive Summary
Sen. Judd Gregg (R- N.H.) plans Senate HELP Committee hearings this fall to consider follow-up legislation to the Project Bioshield Act (S 15) to address, among other topics, corporate liability for products developed under the program. The legislation, approved in the House July 14 following Senate passage May 19, secures $5.6 bil. in funding over the next five years for development of diagnostic and therapeutic countermeasures against bioterrorism agents and ensures rapid regulatory review, when necessary. AdvaMed has backed the Bioshield provisions since the concept was unveiled during President Bush's 2003 State of the Union address. The association also has maintained the importance of liability protection for products used in emergency...